A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2011
08/18/2011	WO2011100197A1 Methods of treating glucose metabolism disorders
08/18/2011	WO2011099872A1 Methods for improving sperm functionality
08/18/2011	WO2011099036A2 Liquid formulation of follicle stimulating hormone
08/18/2011	WO2011099011A2 Treatment of anemia by adnp and adnf polypeptides
08/18/2011	WO2011098990A1 Transferrin for use in the treatment and/or prophylaxis of autoimmune diseases
08/18/2011	WO2011098962A2 Anionic polysaccharides functionalised by at least two hydrophobic groups supported by an at least trivalent spacer
08/18/2011	WO2011098904A1 Iap bir domain binding compounds
08/18/2011	WO2011098829A1 Nucleic acid complexes
08/18/2011	WO2011098806A1 Proteins of the jak, stat, socs and pias families for use in the treatment hypercytokinemia or viral infection
08/18/2011	WO2011098652A1 Applications of the protein muns and the derivates thereof
08/18/2011	WO2011098644A2 Compositions for the treatment of infectious and tumoural diseases
08/18/2011	WO2011098603A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
08/18/2011	WO2011098579A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention
08/18/2011	WO2011098568A1 Lactocepins for use in the treatment of ip-10-mediated inflammatory diseases
08/18/2011	WO2011098499A1 Orally administrable pharmaceutical pellet of epidermal growth factor
08/18/2011	WO2011098262A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
08/18/2011	WO2011098095A1 Peptides binding the tpo receptor
08/18/2011	WO2011097688A1 Protein domains and uses therefor
08/18/2011	WO2011082335A3 Purified bowman-birk protease inhibitor proteins isolated from a soy processing stream
08/18/2011	WO2011076903A9 Mutant nisin ser 29 derivatives and the use thereof
08/18/2011	WO2011072336A8 Antiviral agents
08/18/2011	WO2011063090A3 Peptide protection against ultraviolet light toxicity
08/18/2011	WO2011060789A3 Treatment of acute ischemic stroke or intracranial bleeding with tpa and carbamylated erythropoietin
08/18/2011	WO2011058315A3 Glucose sensor
08/18/2011	WO2011057160A8 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120
08/18/2011	WO2011056930A9 Fragile x mental retardation protein (fmrp), compositions, and methods related thereto
08/18/2011	WO2011056416A3 Cardiomyocyte production
08/18/2011	WO2011050098A3 Compositions, methods and uses for inhibition and/or treatment of influenza infection
08/18/2011	WO2011047269A3 Elongator proteins and use thereof as dna demethylases
08/18/2011	WO2011047051A3 Polymeric systems for the delivery of anticancer agents
08/18/2011	WO2011046832A3 Granulysin in immunotherapy
08/18/2011	WO2011044499A3 Enterotoxigenic e. coli fusion protein vaccines
08/18/2011	WO2011040954A9 Tp53 gene expression and uses thereof
08/18/2011	WO2011038142A3 Bladder cancer specific ligand peptides
08/18/2011	WO2011029008A3 Synbodies to akt1
08/18/2011	WO2011027980A3 Tumor cell-killing peptides
08/18/2011	WO2011000962A9 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
08/18/2011	US20110203007 Assays of neurodegenerative disorders, including frontotemporal dementia and amyotrophic lateral sclerosis
08/18/2011	US20110202033 Compositions and methods for the treatment and prevention of cardiac ischemic injury
08/18/2011	US20110201692 Antimicrobial flush solutions
08/18/2011	US20110201676 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
08/18/2011	US20110201673 Lpl variant therapeutics
08/18/2011	US20110201562 Formulations and method for treating baldness
08/18/2011	US20110201561 Treatment of metastatic colon cancer with b-subunit of shiga toxin
08/18/2011	US20110201560 Peptides for inhibiting the hpv-e6 oncoprotein
08/18/2011	US20110201559 New Optically Pure Compounds for Improved Therapeutic Efficiency
08/18/2011	US20110201558 Anaplerotic Therapy for Alzheimer's Disease and the Aging Brain
08/18/2011	US20110201557 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
08/18/2011	US20110201556 Methods of treating cartilage defects
08/18/2011	US20110201555 Novel estrogen receptor ligands
08/18/2011	US20110201554 Hfsh aqueous formulation
08/18/2011	US20110201553 Systemic Pro-hemostatic Effect of Sympathicomimetics with Agonistic Effects on Alfa-Adrenergic and/or Beta-Adrenergic Receptors of the Sympathetic Nervous System, Related to Improved Clot Strength
08/18/2011	US20110201552 Isolated nucleic acid molecule encoding a neurotrophic growth factor
08/18/2011	US20110201551 Peptide having anti-diabetic activity and use thereof
08/18/2011	US20110201550 Combination of amidine derivatives with cyclic depsipeptides
08/18/2011	US20110201548 Therapeutic agent for acute hepatitis or prophylactic/therapeutic agent for fulminant hepatitis
08/18/2011	US20110201547 Engineered polypeptide agents for targeted broad spectrum influenza neutralization
08/18/2011	US20110201546 Methods of treatment using single doses of oritavancin
08/18/2011	US20110201545 Gel based livestock feed, method of manufacture and use
08/18/2011	US20110201544 Compositions and Methods for Inhibiting the Interaction between CFTR and CAL
08/18/2011	US20110201543 Use of tight junction antagonists in the treatment of acute lung injury and acute respiratory distress
08/18/2011	US20110201542 Myeloid Protein Activation of Anti-Inflammatory and Anti-Hypoxic Pathway
08/18/2011	US20110201541 Tissue occluding agent
08/18/2011	US20110201540 Glycosylation of Molecules
08/18/2011	US20110201539 Detecting succinylacetone
08/18/2011	US20110201115 Method and apparatus for production of a skin graft and the graft produced thereby
08/18/2011	US20110201052 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer
08/18/2011	US20110201044 Tuberculosis diagnostic test
08/18/2011	US20110201030 Human G-Protein Chemokine Receptor (CCR5) HDGNR10
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110200990 RECEPTOR ACTIVATOR OF NF kappa-B
08/18/2011	US20110200693 Increasing the efficiency of utilization of ingested creatine
08/18/2011	US20110200687 Bifeprunox mesylate maintenance dose compositions and methods for using the same
08/18/2011	US20110200679 Method for manufacturing sustained release microsphere by solvent flow evaporation method
08/18/2011	US20110200678 Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution
08/18/2011	US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer
08/18/2011	US20110200660 Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
08/18/2011	US20110200659 System and method for loading a beneficial agent into a medical device
08/18/2011	US20110200642 Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
08/18/2011	US20110200626 Iqgap3 epitope peptides and vaccines containing the same
08/18/2011	US20110200625 Pharmaceutical composition
08/18/2011	US20110200621 Compositions and methods for treating cancer
08/18/2011	US20110200619 Pharmaceutical compounds as cytotoxic agents and uses thereof
08/18/2011	US20110200605 Polypeptides and use thereof
08/18/2011	US20110200600 Diagnosis and prognosis of immune disorders using stat4 expression
08/18/2011	US20110200593 Combination Therapy for the Treatment of Ocular Neovascular Disorders
08/18/2011	US20110200589 Deconvolution method
08/18/2011	US20110200584 Method to stimulate immune function and regeneration
08/18/2011	US20110200582 Lipids, lipid compositions, and methods of using them
08/18/2011	US20110200581 Pharmaceutical compositions
08/18/2011	US20110200580 Methods of treatment and prevention of diet-induced obesity and sequelae thereof
08/18/2011	US20110200578 Intraventricular hemorrhage thrombosis
08/18/2011	US20110200577 Biomatrices to attract and retain regenerative and reparative cells
08/18/2011	US20110200576 Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
08/18/2011	US20110200575 Metallo-lactoferrin-coenzyme compositions to improve sleep patterns
08/18/2011	US20110200574 Use of proteases for gluten intolerance
08/18/2011	US20110200573 Methods of inhibiting retrovirus replication and infectivity
08/18/2011	US20110200564 Diagnosis and treatment of alzheimer's disease (ad)
08/18/2011	US20110200562 Chimeric Cytokine of IL-7 and Beta Chain of HGF and Methods of Use
08/18/2011	US20110200558 Treatment or Prevention of Hepatitis C with Immunomodulator Compounds

1 ... 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 ... 3163